WO2023190293A1 - とろみ状栄養組成物 - Google Patents
とろみ状栄養組成物 Download PDFInfo
- Publication number
- WO2023190293A1 WO2023190293A1 PCT/JP2023/012115 JP2023012115W WO2023190293A1 WO 2023190293 A1 WO2023190293 A1 WO 2023190293A1 JP 2023012115 W JP2023012115 W JP 2023012115W WO 2023190293 A1 WO2023190293 A1 WO 2023190293A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nutritional composition
- kcal
- thick
- thick nutritional
- calorific value
- Prior art date
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 144
- 239000000203 mixture Substances 0.000 title claims abstract description 141
- 235000018102 proteins Nutrition 0.000 claims abstract description 22
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 22
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 22
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 21
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 21
- 150000002632 lipids Chemical class 0.000 claims abstract description 17
- 235000015097 nutrients Nutrition 0.000 claims abstract description 14
- 239000004375 Dextrin Substances 0.000 claims description 17
- 229920001353 Dextrin Polymers 0.000 claims description 17
- 235000019425 dextrin Nutrition 0.000 claims description 17
- 238000011866 long-term treatment Methods 0.000 abstract description 6
- 229920001817 Agar Polymers 0.000 description 24
- 239000008272 agar Substances 0.000 description 21
- 235000010419 agar Nutrition 0.000 description 21
- 229920001277 pectin Polymers 0.000 description 19
- 239000001814 pectin Substances 0.000 description 19
- 235000010987 pectin Nutrition 0.000 description 19
- 238000000034 method Methods 0.000 description 14
- 235000013325 dietary fiber Nutrition 0.000 description 12
- 235000015110 jellies Nutrition 0.000 description 12
- 239000008274 jelly Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 108010046377 Whey Proteins Proteins 0.000 description 9
- 102000007544 Whey Proteins Human genes 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 229920001542 oligosaccharide Polymers 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- -1 tripeptide Proteins 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 235000021119 whey protein Nutrition 0.000 description 7
- 235000010724 Wisteria floribunda Nutrition 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 4
- 108010073771 Soybean Proteins Proteins 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000032050 esterification Effects 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000003002 pH adjusting agent Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000004347 Perilla Nutrition 0.000 description 3
- 244000124853 Perilla frutescens Species 0.000 description 3
- 235000021120 animal protein Nutrition 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 235000019710 soybean protein Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 2
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010035669 Pneumonia aspiration Diseases 0.000 description 2
- 229920001100 Polydextrose Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Chemical compound OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 201000009807 aspiration pneumonia Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000012812 general test Methods 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 235000013856 polydextrose Nutrition 0.000 description 2
- 239000001259 polydextrose Substances 0.000 description 2
- 229940035035 polydextrose Drugs 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000011112 polyethylene naphthalate Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- AOFUBOWZWQFQJU-SNOJBQEQSA-N (2r,3s,4s,5r)-2,5-bis(hydroxymethyl)oxolane-2,3,4-triol;(2s,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O AOFUBOWZWQFQJU-SNOJBQEQSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 239000004377 Alitame Substances 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000134916 Amanita Species 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 208000022540 Consciousness disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- 201000009623 Myopathy Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 239000004384 Neotame Substances 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 244000090599 Plantago psyllium Species 0.000 description 1
- 235000010451 Plantago psyllium Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical group CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 235000019409 alitame Nutrition 0.000 description 1
- 108010009985 alitame Proteins 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 150000001982 diacylglycerols Chemical class 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 229940025902 konjac mannan Drugs 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 235000019412 neotame Nutrition 0.000 description 1
- 108010070257 neotame Proteins 0.000 description 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 208000000689 peptic esophagitis Diseases 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 235000015870 tripotassium citrate Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Definitions
- the present invention relates to a thick nutritional composition.
- Enteral nutrition is more physiological than parenteral nutrition, maintains the original functions of the gastrointestinal tract, such as digestion and absorption, and the function of the intestinal immune system, and can be safely managed with fewer infectious complications. . It is an important nutritional administration method for patients who have difficulty taking oral intake due to significant decline in masticatory/swallowing function or impaired consciousness. Enteral feeding methods include nasal tube feeding and gastrostomy tube feeding, depending on the route of administration. Nutrient compositions come in liquid and semi-solid forms, but both methods of administration allow for administration by natural fall, while also suppressing aspiration pneumonia caused by gastroesophageal reflux to some extent. A thick nutritional composition is known as one that can provide this (Patent Document 1).
- Patent Document 1 Many conventional commercially available thick nutritional compositions have a calorific value of 200 to 400 kcal/piece.
- the required amount of energy is about 1.2 to 1.5 times the normal amount, which is 1,300 to 1,700 kcal/day, and conventional commercial products alone cannot
- three meals for breakfast, lunch, and dinner are not enough to meet the required energy, and liquid food is added as needed. This poses a problem in that it increases the effort and time required for administration.
- nutritional management is usually carried out at 900 to 1100 kcal/day.
- the thick nutritional composition according to (1) above which has a pH of 3.0 to 4.5.
- the thick nutritional composition according to any one of (1) to (3) above which has a viscosity at 25° C. of 1,000 to 4,000 mPa ⁇ s.
- the thick nutritional composition according to any one of (1) to (4) above wherein the blended amount of protein is 2.7 to 5.5 g/100 kcal.
- This nutritional composition is a thick nutritional composition with a calorific value of .1 kcal/g and a calorific value of 450 to 550 kcal/piece.
- the thick nutritional composition of the present invention has an appropriate viscosity while containing nutrients such as protein, lipid, and carbohydrate, and has a calorific value of 2 to 3 bottles per day.
- the effort and time required to administer the nutritional composition can be reduced.
- the thick nutritional composition of the present invention is a thick nutritional composition that does not require rapid administration even when directly connected to a PEG (gastrostomy) catheter due to natural drop, and does not require water administration. It is a thing. Therefore, the patient receiving the drug can reliably and easily ingest nutrients without causing diarrhea. Furthermore, because it has a certain viscosity, unlike liquids, it takes about 30 minutes to stay in the stomach even when administered using a drop or through a nasal tube using a pressurized pump. Because it is administered in a vacuum, reflux is less likely to occur than with liquid nutritional compositions.
- the thick nutritional composition of the present invention can suppress bacterial growth within the PEG catheter after administration of the nutritional agent by setting the pH to an acidic range.
- the thick nutritional composition of the present invention can suppress rapid increases in blood sugar by containing slowly digestible dextrin.
- the thick nutritional composition of the present invention has a calorific value of 450 to 550 kcal/bottle or at least one bottle. If the calorific value per bottle is lower than 450 kcal/bottle, it is preferable because patients undergoing rehabilitation are expected to use 4 bottles per day, and patients undergoing long-term treatment are expected to use 2 bottles per meal. do not have. Moreover, if the amount exceeds 550 kcal/piece, it is not preferable because the amount of calories to be taken in one meal is too large.
- the thick nutritional composition of the present invention has a concentration (specifically, calorific value/g, calorific value per g) of 0.9 to 1.1 kcal/g, preferably 0.95 to 1.05 kcal/g. It is. If the concentration (calorific value/g) is less than 0.9 kcal/g, it is not preferable because the water content of the thick nutritional composition will increase and the amount of nutrients administered to the patient may decrease, resulting in nutritional deficiency. If the concentration (calorific value/g) exceeds 1.1 kcal/g, the water content of the thick nutritional composition will decrease, and water will be added and administered through the PEG (gastrostomy) catheter, increasing the risk of bacterial infection. Therefore, it is not desirable.
- the moisture content of the thick nutritional composition of the present invention is preferably 30 to 95% by mass, preferably 30 to 95% by mass, and more preferably 40 to 90% by mass.
- Thickerened in the thickened nutritional composition of the present invention means that it has a viscosity of 1,000 to 4,000 mPa ⁇ s.
- viscosity is measured according to the method described in the 8th edition of the Food Additives Official Standards "B. General Test Methods, 28. Viscosity Measurement Method 2nd Method Rotational Viscometer Method". For example, it refers to a value measured using a B-type rotational viscometer DV-II+Pro (Brookfield), RB80L (Toki Sangyo Co., Ltd.), or the like.
- the viscosity of the thick nutritional composition of the present invention is preferably 1,000 to 4,000 mPa ⁇ s, preferably 1,500 to 3,000 mPa ⁇ s. If the viscosity is lower than 1,000 mPa ⁇ s, when directly connected to a PEG catheter and administered by natural drop, the thick nutritional composition will be rapidly administered to the stomach, causing symptoms such as diarrhea, which is not preferable. If the viscosity exceeds 4,000 mPa ⁇ s, the fluidity of the thick nutritional composition will deteriorate and administration will take too much time, which is not preferable.
- the pH of the thick nutritional composition of the present invention is preferably 3.0 to 4.5, preferably 3.5 to 4.0. If the pH is lower than 3.0, the acidity becomes strong and a refreshing feeling cannot be obtained, which is not preferable. If the pH exceeds 4.5, it becomes difficult to suppress the growth of bacteria within the PEG catheter when the nutritional composition is used, which is not preferable.
- pH of the thick nutritional composition of the present invention can be adjusted by appropriately setting the amount of a pH adjuster, acidulant, etc. added.
- pH is the value measured according to the method described in "B. General test method, 31. pH measurement method" of the 8th edition of the Food Additives Official Standards.
- the "slowly digestible dextrin" shown in the thick nutritional composition of the present invention is a dextrin that causes a lower increase in blood sugar level after ingestion than normal maltodextrin. Specifically, highly branched dextrins with many branched structures consisting of z and ⁇ -1,6 bonds are preferred. Commercially available products include HBD-20 (Matsuya Chemical Industry Co., Ltd.).
- the amount of "slowly digestible dextrin" shown in the thick nutritional composition of the present invention is preferably 10.0 to 17.2 g/100 kcal (0.36 to 0.76 kcal/g). If the blending amount is lower than 10.0 g/100 kcal (0.36 kcal/g), there is a possibility that sufficient amount of heat cannot be obtained. If it exceeds 17.2 g/100 kcal (0.76 kcal/g), the carbohydrate supply becomes excessive and may induce diabetes.
- any of various known carbohydrates that have been conventionally used in nutritional compositions can be used.
- monosaccharides such as glucose, fructose, and galactose
- disaccharides such as sucrose, lactose, maltose, isomaltose, and trehalose
- starch amylose, amylopectin
- Polysaccharides such as dextrins, starch syrup, reduced starch syrup, honey, isomerized sugar, invert sugar, oligosaccharides (isomalto-oligosaccharides, reduced xylo-oligosaccharides, reduced gentio-oligosaccharides, xylooligosaccharides, gentio-oligosaccharides, nigerooligosaccharides, theandeo-oligosaccharides, soybean oligosaccharides)
- sweetening ingredients that are conventionally known or that will become known in the future can also be used in place of sugars.
- sweet ingredients such as aspartame, acesulfame potassium, sucralose, alitame, neotame, licorice extract (glycyrrhizin), saccharin, sodium saccharin, stevia extract, and stevia powder may be used.
- the thick nutritional composition of the present invention preferably has a protein content of 2.7 to 5.5 g/100 kcal (0.10 to 0.24 kcal/g), preferably 3.3 to 5.0 g/100 kcal (0.10 to 0.24 kcal/g). It is 100kcal (0.12-0.22kcal/g). If the amount of protein blended is less than 2.7 g/100 kcal (0.10 kcal/g), it is not preferable because the required amount of protein cannot be ingested. If the amount of protein added exceeds 5.5 g/100 kcal (0.24 kcal/g), it is not preferable because it may place a burden on the kidney function of elderly people.
- proteins include not only vegetable proteins and animal proteins, but also amino acids and peptides.
- Examples of vegetable proteins include proteins contained in grains such as rice, legumes such as soybeans and tofu, and the like.
- soybean protein may have health functions such as binding to bile acids and promoting the excretion of cholesterol.
- Examples of animal protein include proteins contained in eggs, meat, seafood, milk, and the like.
- whey protein made from milk (whey), casein protein contained in milk, and soybean protein
- whey protein examples include whey protein concentrate (WPC), whey protein isolate (WPI), hydrolyzed whey peptide (WPH), and the like.
- WPC, WPI, soybean protein, etc. may be commercially available. Examples of commercially available products include WPI8855 (manufactured by Fonterra), WPI8899 (manufactured by Fonterra), WPI895 (manufactured by Fonterra), WPC392 (manufactured by Fonterra).
- WPC80 (manufactured by Fonterra), WPC7009 (manufactured by Fonterra), WPC164 (manufactured by Fonterra), WPC162 (manufactured by Fonterra), WPC132 (manufactured by Fonterra), WPC472 (manufactured by Fonterra), Prolina 800 (Fuji Oil (manufactured by Fuji Oil Co., Ltd.), New Fuji Pro 3000 (manufactured by Fuji Oil Co., Ltd.), New Fuji Pro 1700N (manufactured by Fuji Oil Co., Ltd.), and the like.
- Amino acids include essential amino acids such as valine, leucine, isoleucine, lysine, methionine, phenylalanine, threonine, tryptophan, histidine, and glycine, alanine, serine, cysteine, asparagine, glutamine, proline, tyrosine, aspartic acid, glutamic acid, arginine, etc.
- essential amino acids such as valine, leucine, isoleucine, lysine, methionine, phenylalanine, threonine, tryptophan, histidine, and glycine, alanine, serine, cysteine, asparagine, glutamine, proline, tyrosine, aspartic acid, glutamic acid, arginine, etc.
- non-essential amino acids such as carnitine.
- the peptide one in which two or more of the above amino acids are polymerized via a peptide bond (amide bond) can be used.
- the peptide may be a dipeptide, tripeptide, oligopeptide (having about 10 amino acids), or polypeptide (having tens to hundreds of amino acids).
- the polypeptides include proteins such as plant proteins and animal proteins. Note that some oligopeptides, such as lactotripeptide, caseindodecapeptide, and baryltyrosine-containing sardene peptide, may have health functions such as antihypertensive effects.
- proteins, amino acids, or peptides may be used alone or in combination of two or more.
- its viscosity is preferably adjusted by agar having a jelly strength of 10 to 120 g/cm 2 and pectin having a degree of esterification of 50 to 75%.
- the "jelly strength" shown in the thick nutritional composition of the present invention is determined by leaving a 1.5% agar aqueous solution at 20°C for 15 hours, measuring the hardness of the solidified gel, and measuring the surface area of the agar gel by 1 cm2. It is the maximum weight (g) that can be withstood for 20 seconds.
- the hardness of the gel can be measured using a commonly used rheometer or the like.
- the agar that can be used in the thick nutritional composition of the present invention is not particularly limited, and those produced by conventional methods can be used.
- agar is made by freezing and drying the mucilage of red algae such as Amanita spp.
- the agarose and agaropectin have a structure in which galactose and 3,6-andehydrogalactose are alternately polymerized.
- the properties of agar may vary depending on the degree of polymerization and molecular weight of agarose and agaropectin, the amount of sulfate groups and pyruvic acid groups in the agar, etc., but in the thick nutritional composition of the present invention, there are no particular limitations. Either one may be used.
- the jelly strength of agar that can be used in the thick nutritional composition of the present invention is preferably 10 to 120 g/cm 2 . If the jelly strength of agar is lower than 10 g/ cm2 , the molecular weight distribution of the agar is in a small range, and the gelling power is extremely suppressed, so the viscosity of the thick nutritional composition decreases, making it difficult to use the PEG catheter. This is undesirable because it flows rapidly and may cause the nutritional composition to leak from around the PEG catheter or cause diarrhea in the patient.
- the agar When the jelly strength of agar exceeds 120 g/ cm2 , the agar has a large molecular weight distribution and has very strong gelling power, so the viscosity of the thick nutritional composition increases and the natural drop from the PEG catheter increases. When the nutritional composition is administered using the PEG catheter, it takes a long time to pass through the PEG catheter, which is not preferable.
- the amount of agar that can be used in the thick nutritional composition of the present invention is preferably 0.04 to 0.20% by mass, preferably 0.06 to 0.20% by mass based on the total amount of the thick nutritional composition. It is 0.10% by mass. If the amount of agar added is less than 0.04% by mass, the solid content of the thick nutritional composition will not be dispersed but will precipitate, which may cause blockage of the PEG catheter, which is not preferable. If the amount of agar exceeds 0.20% by mass, the viscosity of the thick nutritional composition increases, and when administering the thick nutritional composition from a PEG catheter using the natural drop, it becomes difficult to pass through the PEG catheter. It takes a long time for this to occur, which is not desirable.
- examples of agar that can be used in the thick nutritional composition of the present invention include Ultra Agar UX-30 (Ina Foods Co., Ltd., jelly strength: 30 g/cm 2 ), Ultra Agar UX-100 (Ina Shokuhin Kogyo Co., Ltd., Jelly strength: 100g/cm 2 ), Ultra Agar AX-30, Ina Foods Kogyo Co., Ltd., Jelly strength: 30g/cm 2 ), Ultra Agar AX-100, Ina Foods Kogyo Co., Ltd., Jelly strength: 100g/cm 2 ), Ultra Agar BX-30, Ina Foods Co., Ltd., jelly strength: 30g/cm 2 ), Ultra Agar BX-100, Ina Foods Co., Ltd., jelly strength: 100g/cm 2 ), etc. It will be done.
- the raw materials for pectin that can be used in the thick nutritional composition of the present invention are widely found in plant tissues, but are mainly derived from the peel of citrus fruits such as limes, lemons, and oranges, apple pomace, and beet pulp.
- the extracted material can be used.
- the pectin that can be used in the thick nutritional composition of the present invention preferably has a high methoxyl pectin with a degree of esterification of 50 to 75%, preferably 68 to 75%. Low methoxyl pectin with a degree of esterification lower than 50% is not preferred because the thick nutritional composition will gel.
- the amount of pectin that can be used in the thick nutritional composition of the present invention is preferably 0.45 to 0.60% by mass, preferably 0.50 to 0.60% by mass based on the total amount of the thick nutritional composition. It is 0.55% by mass. If the amount of pectin is less than 0.45% by mass, the solid content of the thick nutritional composition will not be dispersed but will precipitate, which may cause occlusion of the PEG catheter, which is not preferable. When the amount of pectin added exceeds 0.60% by mass, the viscosity of the thick nutritional composition increases, and when administering the thick nutritional composition from a PEG catheter using the natural fall, it is difficult to pass through the PEG catheter. It takes a long time for this to occur, which is not desirable.
- pectin TYPE YM -150 -LJ specifically, GENU PECTIN TYPE YM -150 -LJ, GENU PECTIN TYPE YM -115 -LJ, GENU PECTIN TYPE JM -115- H-J, GENU pectin type JM-150-J, GENU pectin type JMJ-J (Taiyo Kagaku Co., Ltd.), UNIPECTINE AYD 30T, UNIPECTINE AYD 358, UNIPE CTINEAYD 380B (Unitech Foods Co., Ltd.) is mentioned.
- dietary fibers other than agar and pectin that have been conventionally utilized in nutritional compositions.
- Water-soluble dietary fibers such as chemically modified polysaccharides, polydextrose, indigestible oligosaccharides, maltitol, inulin, carrageenan, wheat bran, and indigestible dextrins (e.g., Pine Fiber C (Matsuya Kagaku Kogyo Co., Ltd.)), etc. It will be done.
- Pine Fiber C Matsuya Kagaku Kogyo Co., Ltd.
- the amount of dietary fiber that can be used in the thick nutritional composition of the present invention can be adjusted as appropriate depending on the subject to whom it is applied.
- the lipid to be added to the thick nutritional composition of the present invention any of various known lipids that have been conventionally used in nutritional compositions can be used. Linseed oil, perilla oil, olive oil, sesame oil, rice bran oil, safflower oil, perilla oil, soybean oil, corn oil, rapeseed oil, germ oil, perilla oil, palm kernel oil, sunflower oil, cottonseed oil, coconut oil, peanut oil
- vegetable oils and fats such as fish oil, animal oils and fats such as milk fat, medium chain fatty acids, and highly unsaturated fatty acids. These may be used alone or in combination of two or more.
- processing agents such as DHA, EPA, and diacylglycerol can also be added.
- the amount of lipid in the thick nutritional composition can be adjusted as appropriate depending on the subject, but it should be 1.0 to 8.0 g/100 kcal (0.08 to 0.79 kcal) based on the total amount of the thick nutritional composition. /g) is preferable.
- Vitamins may be added to the thick nutritional composition of the present invention.
- vitamins include vitamin B1, vitamin B2, vitamin B6, vitamin B12, niacin, pantothenic acid, folic acid, biotin, vitamin C, vitamin A, vitamin D, vitamin E, and vitamin K, and multiple of these should be combined as much as possible. It is preferable to mix it.
- vitamin derivatives may be used as vitamins.
- the pH of the thick nutritional composition of the present invention can be adjusted with a pH adjuster.
- the pH adjuster has the function of adjusting the pH of the thick nutritional composition.
- Examples of the pH adjuster include, but are not limited to, citric acid, gluconic acid, succinic acid, potassium carbonate, sodium hydrogen carbonate, carbon dioxide, lactic acid, sodium lactate, sodium citrate, adipic acid, and the like. These pH adjusters may be used alone or in combination of two or more.
- the thick nutritional composition of the present invention may contain an acidulant.
- Acidulants have functions such as imparting sourness to nutritional compositions, preventing oxidation of foods, and adjusting pH.
- As the acidulant there are no particular limitations, but acetic acid, citric acid, succinic acid, lactic acid, malic acid, tartaric acid, gluconic acid, phosphoric acid, etc. can be used. These acidulants may be used alone or in combination of two or more. Flavoring agents and fruit juices may also be added to the thick nutritional composition of the present invention.
- the amount of the above-mentioned food additives in the thick nutritional composition can be adjusted as appropriate depending on the subject to whom it is applied.
- the ingredients that may be added to the thick nutritional composition of the present invention other than the essential ingredients are not particularly limited, and may be determined as appropriate depending on the administration method, the condition of the elderly or patient to whom the thick nutritional composition is applied, etc. sell. Furthermore, for patients who require whole-body care, it is preferable to include vitamins and minerals necessary to maintain their nutritional status. It is preferable to add dietary fiber to elderly people with impaired digestive function in order to improve constipation caused by administration of the thick nutritional composition.
- the thick nutritional composition of the present invention is adjusted to an appropriate viscosity using agar and pectin, and contains necessary nutritional sources in a well-balanced manner.
- the thick nutritional composition of the present invention can be produced by a known method. For example, it can be produced by adding nutrients, agar, pectin, and other necessary ingredients to heated water and stirring. Alternatively, prepare a solution of agar dissolved in warmed water and a solution of pectin dissolved in water, add nutrients and other desired ingredients to either, and mix and stir the two solutions. It can be manufactured in
- the obtained thick nutritional composition can be manufactured into a product by, for example, being continuously sterilized and then filled into a container.
- the continuous sterilization method includes, but is not limited to, ultra-high temperature short-time (UHT) sterilization, hot water sterilization, batch sterilization, and combinations thereof.
- UHT ultra-high temperature short-time
- the sterilization is preferably carried out in a short period of time. By performing sterilization in a short period of time, deterioration of the components contained in the thick nutritional composition can be suppressed.
- the container to be filled with the thick nutritional composition is not particularly limited, and any known container may be used.
- Examples of such containers include Tetra Pak (registered trademark), cart cans, glass containers, metal cans, aluminum pouches, plastic containers, and the like. Among these, it is preferable to use a plastic container.
- the raw materials for the plastic container include polyethylene (PE), polypropylene (PP), polyvinyl chloride (PVC), polyvinyl acetate (PVAc), polycarbonate (PC), polybutylene terephthalate (PBT), polyethylene terephthalate (PET), It is preferable to use polyethylene naphthalate (PEN), ethylene-vinyl acetate copolymer (EVA), ethylene- ⁇ -olefin copolymer, polyfluorocarbon, polyimide, and the like.
- PE polyethylene
- PP polypropylene
- PVC polyvinyl chloride
- PVAc polyvinyl acetate
- PC polycarbonate
- PBT polybutylene terephthalate
- PET polyethylene terephthalate
- PEN polyethylene naphthalate
- EVA ethylene-vinyl acetate copolymer
- EVA ethylene- ⁇ -olefin copolymer
- polyfluorocarbon polyimide
- the plastic container further includes polyethylene terephthalate (PET), polyethylene naphthalate (PEN), ethylene-vinyl alcohol copolymer (EVOH), polyvinylidene chloride (PVDC), polyacrylonitrile, polyvinyl alcohol, polyamide, polyester, etc.
- Gas barrier resin layer Gas barrier inorganic layers such as aluminum foil, aluminum vapor deposited film, silicon oxide film, and aluminum oxide film may be used in appropriate combination. By providing the gas barrier layer, deterioration of the thick nutritional composition due to oxygen, water vapor, etc. can be prevented.
- the container may be further shielded from light.
- blocking light for example, deterioration of vitamin A, vitamin B2, vitamin C, vitamin K, etc. that may be included in the thick nutritional composition due to light can be suppressed.
- the containers mentioned above may be commercially available, such as soft pouches (Fuji Seal Co., Ltd.), bottled pouches (Toppan Printing Co., Ltd.), spouches (Dainippon Printing Co., Ltd.), and cheer packs (Hosokawa Yoko Co., Ltd.). etc. can be used.
- Example 1 The preparation method for preparing 4000g is described below.
- the blending amount of each raw material is as shown in Table 1.
- 1500 g of blended water was weighed into a 5 L stainless steel beaker and heated to 80° C. or higher in a hot water bath.
- agar with a jelly strength of 30 g/cm 2 Ultra Agar UX-30, Ina Food Industry Co., Ltd.
- pectin with an esterification degree of 70 GGU Pectin JM-150-J, Sansho Co., Ltd.
- the properties of the obtained thick nutritional composition were observed, and the values of various components were calculated and the physical properties were evaluated.
- the method is as follows. (1) Calories were calculated as (4kcal ⁇ carbohydrate content)+(9kcal ⁇ lipid content)+(4kcal ⁇ protein content)+(2kcal ⁇ dietary fiber content) and expressed as kcal. (2) pH: After the thick nutritional composition was allowed to stand at 25° C. for 24 hours, the pH was measured using a pH meter METTLER TOLEDO MP220 (METTLER TOLEDO).
- Viscosity After leaving the thick nutritional composition at 25°C for 24 hours, measure using a B-type rotational viscometer (manufacturer: BROOKFIELD, model: DV-II+Pro, measurement conditions: rotation speed 6 rpm, measurement time 1 minute, rotor No. .63).
- Calorific value when using 2 to 3 bottles per day Calculated from the amount of heat per bottle.
- ⁇ Within the appropriate range (900 to 1100 kcal/day) when using 2 bottles per day, or within the appropriate range (1300 to 1700 kcal/day) when using 3 bottles per day.
- ⁇ Outside the appropriate range (900-1100 kcal/day) when using 2 bottles a day, or outside the appropriate range (1300-1700 kcal/day) when using 3 bottles a day.
- the calorific value per bottle of the obtained thick nutritional composition was 499 kcal, the concentration (calorific value/g) was 1.0 kcal/g, the pH was 3.88, and the viscosity was 2,200 mPa ⁇ s. there were.
- the calorific value per two bottles is 998 kcal, and the calorific value per three bottles is 1,497 kcal, which is within the appropriate range when using two bottles per day and within the appropriate range when using three bottles per day. Ta.
- Table 2 The results are shown in Table 2.
- Example 2 Example 1 except that the amount of slowly digestible dextrin, which is a carbohydrate, was changed to 9.0% by mass, and the amount of fat (vegetable oil), which is a lipid, was changed to 3.5% by mass. Exactly the same preparation method was repeated to obtain a thick nutritional composition.
- the calorific value per bottle of the obtained thick nutritional composition was 451 kcal, the concentration was 0.9 kcal/g, the pH was 3.95, and the viscosity was 1,800 mPa ⁇ s.
- the calorific value per two bottles is 902 kcal, and the calorific value per three bottles is 1,353 kcal, which is within the appropriate range when using two bottles per day and within the appropriate range when using three bottles per day. Ta.
- Table 2 The results are shown in Table 2.
- Example 3 A thick nutritional composition was obtained by repeating the same preparation method as in Example 1, except that the amount of slowly digestible dextrin, which is a carbohydrate, was changed to 17.3% by mass.
- the calorific value per bottle of the obtained thick nutritional composition was 549 kcal, the concentration was 1.1 kcal/g, the pH was 3.80, and the viscosity was 3,800 mPa ⁇ s.
- the calorific value per two bottles is 1,098 kcal, and the calorific value per three bottles is 1,647 kcal, which is within the appropriate range when using two bottles per day and within the appropriate range when using three bottles per day. Met.
- the results are shown in Table 2.
- Example 1 was exactly the same as Example 1, except that the amount of slowly digestible dextrin, which is a carbohydrate, was changed to 17.4% by mass, and the amount of whey protein (WPC392), which was a protein, was changed to 2.7% by mass.
- the preparation method was repeated to obtain a thick nutritional composition.
- the calorific value per bottle of the obtained thick nutritional composition was 505 kcal, the concentration was 1.0 kcal/g, the pH was 3.99, and the viscosity was 1,100 mPa ⁇ s.
- the calorific value per two bottles is 1,010 kcal
- the calorific value per three bottles is 1,515 kcal, which is within the appropriate range when using two bottles per day and within the appropriate range when using three bottles per day. Met.
- the results are shown in Table 2.
- Example 1 A thick nutritional composition was obtained by repeating the same preparation method as in Example 1, except that the amount of slowly digestible dextrin, which is a carbohydrate, was changed to 10.0% by mass.
- the calorific value per bottle of the obtained thick nutritional composition was 403 kcal, the concentration was 0.8 kcal/g, the pH was 4.01, and the viscosity was 1,700 mPa ⁇ s.
- the calorific value per two bottles is 806 kcal, and the calorific value per three bottles is 1,209 kcal, which is outside the appropriate range when using two bottles per day and outside the appropriate range when using three bottles per day. Ta.
- the results are shown in Table 2.
- one bottle of the thick nutritional composition of Example 1 or 3 can be added to achieve the appropriate range, although it requires effort and time for management.
- Example 2 A thick nutritional composition was obtained by repeating the same preparation method as in Example 1, except that the amount of slowly digestible dextrin, which is a carbohydrate, was changed to 20.0% by mass.
- the calorific value per bottle of the obtained thick nutritional composition was 604 kcal, the concentration was 1.2 kcal/g, the pH was 3.77, and the viscosity was 4,200 mPa ⁇ s.
- the calorific value per two bottles is 1,208 kcal, and the calorific value per three bottles is 1,812 kcal, which is outside the appropriate range when using two bottles per day and outside the appropriate range when using three bottles per day. Met.
- the results are shown in Table 2.
- one bottle can be used to replace the thick nutritional composition of Example 1 or 2, although it takes time and effort to manage in order to maintain the appropriate range.
- Example 3 A thick nutritional composition was obtained by repeating the same preparation method as in Example 1, except that the amount of filling into the aluminum pouch with a spout was changed to 300 g per pouch.
- the calorific value per one bottle of the obtained thick nutritional composition is 299 kcal
- the calorific value per two bottles is 599 kcal
- the calorific value per three bottles is 898 kcal, which is an appropriate range when using two bottles per day. It was also outside the appropriate range when using 3 bottles per day.
- Table 2 one bottle can be used to replace the thick nutritional composition of Examples 1, 2, or 3, although it takes time and effort to manage it in order to keep it in an appropriate range.
- the concentration of the thick nutritional composition is 0.9 to 1.1 kcal/g, and the calorific value per bottle is 450 to 550 kcal/g.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023539932A JPWO2023190293A1 (enrdf_load_stackoverflow) | 2022-03-30 | 2023-03-27 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022-055016 | 2022-03-30 | ||
| JP2022055016 | 2022-03-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2023190293A1 true WO2023190293A1 (ja) | 2023-10-05 |
Family
ID=88201632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2023/012115 WO2023190293A1 (ja) | 2022-03-30 | 2023-03-27 | とろみ状栄養組成物 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2023190293A1 (enrdf_load_stackoverflow) |
| WO (1) | WO2023190293A1 (enrdf_load_stackoverflow) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011004702A (ja) * | 2009-06-29 | 2011-01-13 | Asahi Kasei Pharma Kk | 食物繊維含有栄養組成物 |
| JP2015131779A (ja) * | 2014-01-10 | 2015-07-23 | テルモ株式会社 | とろみ状栄養組成物 |
| WO2015146461A1 (ja) * | 2014-03-28 | 2015-10-01 | テルモ株式会社 | 大豆たんぱく質含有とろみ状栄養組成物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0213612D0 (en) * | 2002-06-13 | 2002-07-24 | Novartis Nutrition Ag | Organic compounds |
| EP2999359A1 (en) * | 2013-05-01 | 2016-03-30 | Abbott Laboratories | Methods for enhancing aged muscle regeneration |
-
2023
- 2023-03-27 JP JP2023539932A patent/JPWO2023190293A1/ja active Pending
- 2023-03-27 WO PCT/JP2023/012115 patent/WO2023190293A1/ja active Application Filing
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011004702A (ja) * | 2009-06-29 | 2011-01-13 | Asahi Kasei Pharma Kk | 食物繊維含有栄養組成物 |
| JP2015131779A (ja) * | 2014-01-10 | 2015-07-23 | テルモ株式会社 | とろみ状栄養組成物 |
| WO2015146461A1 (ja) * | 2014-03-28 | 2015-10-01 | テルモ株式会社 | 大豆たんぱく質含有とろみ状栄養組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2023190293A1 (enrdf_load_stackoverflow) | 2023-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI573594B (zh) | Semi-solid nutrition | |
| MXPA01013333A (es) | Composicion nutricional gelificada y proceso. | |
| JP5261114B2 (ja) | 酸性タイプ液状経腸栄養剤 | |
| CN110944659A (zh) | 高卡路里营养组合物和包装体 | |
| JP7656399B2 (ja) | 高カロリー栄養組成物 | |
| JP5902815B2 (ja) | 酸性液状栄養剤 | |
| WO2015146460A1 (ja) | 液体栄養組成物 | |
| JPWO2019017016A1 (ja) | 包装体 | |
| TW201334702A (zh) | 胃造口用半固形化營養劑 | |
| JP7116044B2 (ja) | 高カロリー栄養組成物および包装体 | |
| JP6084092B2 (ja) | とろみ状栄養組成物 | |
| JP6300600B2 (ja) | 栄養食品 | |
| US20030091613A1 (en) | Gelled nutritional composition and process | |
| JP6347954B2 (ja) | とろみ状栄養組成物 | |
| JP5329280B2 (ja) | 酸性タイプ液状経腸栄養剤 | |
| JP6575962B2 (ja) | とろみ状栄養組成物 | |
| TW201336428A (zh) | 半固形化營養劑 | |
| WO2023190293A1 (ja) | とろみ状栄養組成物 | |
| TWI544876B (zh) | Gastro-intubation with semi-solid nutrition | |
| JP7579733B2 (ja) | 半固形栄養組成物 | |
| JP2020200046A (ja) | 包装体 | |
| JP2015160822A (ja) | 胃瘻用半固形栄養組成物 | |
| JPWO2019017005A1 (ja) | 高カロリー栄養組成物および包装体 | |
| WO2015146461A1 (ja) | 大豆たんぱく質含有とろみ状栄養組成物 | |
| JP6087191B2 (ja) | 胃瘻用半固形栄養組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 2023539932 Country of ref document: JP |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23780303 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 23780303 Country of ref document: EP Kind code of ref document: A1 |